Page last updated: 2024-10-28

hydralazine and Granulomatosis with Polyangiitis

hydralazine has been researched along with Granulomatosis with Polyangiitis in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
DiLorenzo, AM1
Pasieka, HB1
Cardis, MA1

Other Studies

1 other study available for hydralazine and Granulomatosis with Polyangiitis

ArticleYear
An Edematous and Ulcerative Eruption With Nasolabial Sparing in an Older Woman.
    JAMA dermatology, 2020, 10-01, Volume: 156, Issue:10

    Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antihypertensive Agents; Biopsy; B

2020